Skip to main navigation

Life sciences: Driving innovation in a time of change - Ernst & Young - Mauritius

  • Share

Life sciences: the pulse of innovation

Life sciences companies — from emerging to multinational — are facing challenging times as stakeholder expectations are changing, development pipelines are declining and access to healthcare takes on new importance. Success requires flexible strategies and innovative business models.

Ernst & Young’s Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential — a team with deep technical experience in providing assurance, tax, transaction and advisory services.

Whether it’s forming the right alliances, improving operations, exploring new markets or gaining industry insights, we can help you execute for success in today’s complex, competitive and risk-driven environment.

Biotechnology

Biotechnology

Biotech companies are delivering new levels of health, prosperity and sustainability across the world.

Pharmaceutical

Pharmaceutical

Key drivers are reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and evolving customer needs.

Medical Technology

Medical technology

Fundamental drivers in the global healthcare economy suggest demand for medical technology products should be robust for years to come.

Life Sciences

Couple061912
Beyond borders: global biotech report 2012
As serious resource constraints continue to plague the industry, how can biotech innovation be sustained? Delve into our 26th edition for key findings and insights.

Watch the Pharma 3.0 webcast 1 minute recap

Webcast: Pharma 3.0: meeting the challenge 
View a recap of our latest Pharma 3.0 discussion. Can your life sciences company improve its communications with payers and practitioners?

Register now for Webcast

Progressions 2011: Building Pharma 3.0
A transformation of the pharmaceutical industry is underway as companies begin shifting from producing new medicines to demonstrating improved health outcomes. No longer the dominant health care player, pharma has a new focus. We report on pharma’s progress in creating new business models and partnerships focused on technology and sustainability.

Global insights
Also visit our Global Life Sciences pages for the latest news, insights and contacts.

Back to top